Cellectar Biosciences Q3 EPS $(0.46) Beats $(0.56) Estimate
Benzinga Newsdesk 8 hours ago
NewsEarningsEarnings Beats
Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.56) by 17.86 percent. This is a 67.38 percent increase over losses of $(1.41) per share
Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.56) by 17.86 percent. This is a 67.38 percent increase over losses of $(1.41) per share from the same period last year.